MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 05-16-2026
Zynerba Pharmaceuticals Long Term Debt Current 2011-2026 | ZYNE
Annual Long Term Debt Current Zynerba Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 215 K | 209 K | 110 K | 244 K | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 244 K | 110 K | 194 K |
Long Term Debt Current of other stocks in the Drug manufacturers industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
956 K | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
59.5 K | - | - | $ 36.6 M |  USA |
 |
Cumberland Pharmaceuticals
CPIX
|
468 K | $ 5.49 | -4.02 % | $ 81.6 M | USA |
 |
HEXO Corp.
HEXO
|
914 K | - | 2.45 % | $ 38.1 M |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
12.5 M | - | -0.1 % | $ 2.03 B |  Schweden |
 |
AcelRx Pharmaceuticals
ACRX
|
100 K | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
1.08 M | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
343 K | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
4.36 M | - | - | $ 754 M | USA |
 |
Agile Therapeutics
AGRX
|
366 K | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
634 K | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
337 K | $ 2.75 | -1.43 % | $ 1.05 B | Canada |
 |
Athenex
ATNX
|
2.09 M | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
887 K | $ 36.78 | 9.91 % | $ 1.35 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
582 K | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
13 M | - | - | $ 11.5 B | USA |
 |
Organogenesis Holdings
ORGO
|
4.95 M | $ 2.51 | 1.21 % | $ 318 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
1.53 M | - | -39.89 % | $ 27.7 M | USA |
 |
Canopy Growth Corporation
CGC
|
7.46 M | $ 1.02 | -0.31 % | $ 110 M | Canada |
 |
Pacira BioSciences
PCRX
|
8.89 M | $ 23.41 | 0.86 % | $ 1.08 B | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
58 K | $ 1.1 | -1.08 % | $ 1.37 M | USA |
 |
Solid Biosciences
SLDB
|
2.1 M | $ 6.57 | - | $ 575 M | USA |
 |
Aurora Cannabis
ACB
|
5.38 M | $ 3.3 | -2.51 % | $ 181 M | Canada |
 |
Jupiter Wellness
JUPW
|
23.5 K | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
2.06 M | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
1.03 M | $ 1.06 | -1.85 % | $ 101 M | Canada |
 |
Tilray
TLRY
|
2.47 M | $ 5.08 | -1.84 % | $ 3.14 B | Canada |
 |
Evolus
EOLS
|
2.53 M | $ 6.79 | 1.27 % | $ 438 M | USA |
 |
Sundial Growers
SNDL
|
35.5 M | $ 1.45 | -1.03 % | $ 3.37 M | Canada |
 |
Emergent BioSolutions
EBS
|
2.4 M | $ 8.24 | 3.84 % | $ 441 M | USA |
 |
Veru
VERU
|
759 K | $ 3.03 | -2.26 % | $ 44.4 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.05 M | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
778 K | $ 0.69 | -2.95 % | $ 2.78 M | USA |
 |
Assertio Holdings
ASRT
|
240 K | $ 23.48 | 0.09 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
1.21 M | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
613 K | - | - | $ 1.42 B | USA |
 |
Bausch Health Companies
BHC
|
61 M | $ 5.18 | - | $ 1.92 B | Canada |
 |
PetIQ
PETQ
|
7.61 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
1.1 M | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
1.25 M | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
483 K | $ 4.24 | -2.75 % | $ 212 M | USA |
 |
PLx Pharma
PLXP
|
622 K | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
109 M | $ 15.81 | -2.44 % | $ 18.4 B | USA |
 |
Zomedica Corp.
ZOM
|
717 K | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
1.16 M | $ 0.67 | -2.36 % | $ 24.1 M | USA |
 |
Tricida
TCDA
|
2.74 M | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
71.6 K | $ 0.77 | 7.6 % | $ 3.3 M |  China |
 |
TherapeuticsMD
TXMD
|
975 K | $ 1.85 | -1.54 % | $ 21.4 M | USA |